Literature DB >> 23831295

Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditions.

Rudolf Martini1, Dennis Klein, Janos Groh.   

Abstract

Wallerian degeneration (WD) and inherited demyelinating neuropathies of the Charcot-Marie-Tooth type 1 (CMT1) appear to represent completely distinct events. CMT1-like diseases are chronic disorders of peripheral nerves that are genetically caused and lead to secondary neurodegenerative events, resulting in usually non-treatable disabilities, whereas WD is an acute, usually transient, reaction on injuries, aiming to allow peripheral nerve regeneration. Despite these differences, there are some striking similarities regarding molecular characteristics of neural cells in the affected peripheral nerves. The most conspicuous similarities might comprise the inflammatory component in both situations, as identified in appropriate mouse models. However, although inflammation is a beneficial component in WD, leading to removal of regrowth-repellent myelin debris, inflammation in CMT1 mouse models causes damage of initially intact nerve fibers. We hypothesize that, in CMT1 models, molecular pathways are activated that are shared with an important repair program after peripheral nerve injury, but lead to neural perturbation when activated under nonlesion conditions, as is the case in CMT1. These novel insights into the pathogenesis of CMT1 might be instrumental for the development of new therapeutic options in humans.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23831295     DOI: 10.1016/j.ajpath.2013.06.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.

Authors:  Robert Fledrich; Ruth M Stassart; Axel Klink; Lennart M Rasch; Thomas Prukop; Lauren Haag; Dirk Czesnik; Theresa Kungl; Tamer A M Abdelaal; Naureen Keric; Christine Stadelmann; Wolfgang Brück; Klaus-Armin Nave; Michael W Sereda
Journal:  Nat Med       Date:  2014-08-24       Impact factor: 53.440

2.  Neutrophils Are Critical for Myelin Removal in a Peripheral Nerve Injury Model of Wallerian Degeneration.

Authors:  Jane A Lindborg; Matthias Mack; Richard E Zigmond
Journal:  J Neurosci       Date:  2017-09-14       Impact factor: 6.167

3.  Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.

Authors:  Benedetta Elena Fornasari; Giulia Ronchi; Davide Pascal; Davide Visigalli; Giovanna Capodivento; Lucilla Nobbio; Isabelle Perroteau; Angelo Schenone; Stefano Geuna; Giovanna Gambarotta
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-19

Review 4.  A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models.

Authors:  Sandy Eldridge; Liang Guo; John Hamre
Journal:  Toxicol Pathol       Date:  2019-07-22       Impact factor: 1.902

5.  Late onset neuropathy with spontaneous clinical remission in mice lacking the POZ domain of the transcription factor Myc-interacting zinc finger protein 1 (Miz1) in Schwann cells.

Authors:  Adrián Sanz-Moreno; David Fuhrmann; Armin Zankel; Herbert Reingruber; Lara Kern; Dies Meijer; Axel Niemann; Hans-Peter Elsässer
Journal:  J Biol Chem       Date:  2014-11-21       Impact factor: 5.157

6.  Neuregulin-1 alleviates Charcot-Marie-Tooth disease in rats.

Authors:  Rudolf Martini
Journal:  Nat Med       Date:  2014-09       Impact factor: 53.440

7.  Macrophage Depletion Ameliorates Peripheral Neuropathy in Aging Mice.

Authors:  Xidi Yuan; Dennis Klein; Susanne Kerscher; Brian L West; Joachim Weis; Istvan Katona; Rudolf Martini
Journal:  J Neurosci       Date:  2018-04-30       Impact factor: 6.167

8.  Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth.

Authors:  Nevena Tzekova; André Heinen; Sebastian Bunk; Corinna Hermann; Hans-Peter Hartung; Birgit Reipert; Patrick Küry
Journal:  J Neuroinflammation       Date:  2015-05-29       Impact factor: 8.322

9.  Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B.

Authors:  Dennis Klein; Janos Groh; Andreas Weishaupt; Rudolf Martini
Journal:  J Neuroinflammation       Date:  2015-03-12       Impact factor: 8.322

10.  Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.

Authors:  Ilya Chumakov; Aude Milet; Nathalie Cholet; Gwenaël Primas; Aurélie Boucard; Yannick Pereira; Esther Graudens; Jonas Mandel; Julien Laffaire; Julie Foucquier; Fabrice Glibert; Viviane Bertrand; Klaus-Armin Nave; Michael W Sereda; Emmanuel Vial; Mickaël Guedj; Rodolphe Hajj; Serguei Nabirotchkin; Daniel Cohen
Journal:  Orphanet J Rare Dis       Date:  2014-12-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.